Search

Search Constraints

You searched for: Author/Creator Lardon, Filip

Search Results

1. 453 Novel combination immunotherapy for boosting and priming immune responses in pancreatic cancer: strong anti-tumour effects with interleukin-15 and CD40 agonist treatment. (9th November 2020)

2. 453 Novel combination immunotherapy for boosting and priming immune responses in pancreatic cancer: strong anti-tumour effects with interleukin-15 and CD40 agonist treatment. (9th November 2020)

4. APR-246 (PRIMA-1MET) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines. Issue 2 (1st June 2016)

6. Decreased expression of ABAT and STC2 hallmarks ER‐positive inflammatory breast cancer and endocrine therapy resistance in advanced disease. Issue 6 (4th March 2015)

7. Deep sequencing of the TP53 gene reveals a potential risk allele for non–small cell lung cancer and supports the negative prognostic value of TP53 variants. Issue 2 (February 2017)

8. Evaluation of Cytologic Sample Preparations for Compatibility With Nucleic Acid Analysis. Issue 2 (20th September 2021)

9. In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53. Issue 5 (5th April 2019)